Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Jazz Pharmaceuticals Stock News

JAZZNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$118.19

-1.86-1.55%

At close: -

$118.19

0.000.00%

After Hours: 4:09 PM EDT

Q1 2025 earnings announcement after the market close today

Conference call scheduled today at 16:30 PM Click to view the webcast

Jazz Pharmaceuticals (JAZZ) Forecast

News

Earnings Jazz Pharmaceuticals (JAZZ) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Latest Jazz Pharmaceuticals Stock News | NASDAQ:JAZZ | Benzinga

Get the latest news on Jazz Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Jazz Pharmaceuticals performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, May 05, 2025

Preview: Jazz Pharmaceuticals's Earnings
Benzinga Insights - 16 hours ago

Friday, April 25, 2025

Jazz Pharma Secures CHMP Support for Zanidata...
Benzinga Newsdesk - Apr 25, 2025, 11:30AM

Thursday, April 10, 2025

Where Jazz Pharmaceuticals Stands With Analysts
Benzinga Insights - Apr 10, 2025, 3:00PM
Needham Reiterates Buy on Jazz Pharmaceutical...
Benzinga Newsdesk - Apr 10, 2025, 7:16AM

Tuesday, April 08, 2025

Jazz Pharmaceuticals Enters Preliminary $145M...
Benzinga Newsdesk - Apr 8, 2025, 5:13PM

Monday, March 10, 2025

DraftKings To Rally Over 29%? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor - Mar 10, 2025, 12:16PM
HC Wainwright & Co. Maintains Buy on Jazz Pha...
Benzinga Newsdesk - Mar 10, 2025, 8:04AM

Friday, March 07, 2025

Morgan Stanley Assumes Jazz Pharmaceuticals a...
Benzinga Newsdesk - Mar 7, 2025, 12:37PM
UBS Upgrades Jazz Pharmaceuticals to Buy, Rai...
Benzinga Newsdesk - Mar 7, 2025, 9:19AM

Thursday, March 06, 2025

Cancer-Focused Zymeworks' Q4 Earnings Miss Expectations, Reprioritize Resources To Focus On ZW251
Vandana Singh - Mar 6, 2025, 1:18PM
Truist Securities Maintains Buy on Jazz Pharm...
Benzinga Newsdesk - Mar 6, 2025, 10:46AM

Wednesday, March 05, 2025

A Glimpse Into The Expert Outlook On Jazz Pharmaceuticals Through 12 Analysts
Benzinga Insights - Mar 5, 2025, 3:00PM
Needham Reiterates Buy on Jazz Pharmaceutical...
Benzinga Newsdesk - Mar 5, 2025, 11:46AM
Jazz Pharma To Buy Chimerix For $935 Million, Strengthening Rare Cancer Pipeline
Vandana Singh - Mar 5, 2025, 8:41AM
Jazz Pharmaceuticals To Acquire Chimerix For ...
Benzinga Newsdesk - Mar 5, 2025, 7:04AM

Thursday, February 27, 2025

Barclays Maintains Overweight on Jazz Pharmac...
Benzinga Newsdesk - Feb 27, 2025, 9:08AM

Wednesday, February 26, 2025

Cantor Fitzgerald Downgrades Jazz Pharmaceuti...
Benzinga Newsdesk - Feb 26, 2025, 5:40PM
CrowdStrike To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor - Feb 26, 2025, 2:03PM
Watching Jazz Pharmaceuticals; Shares See Vol...
Benzinga Newsdesk - Feb 26, 2025, 1:52PM
Jazz Pharmaceuticals shares are trading highe...
Benzinga Newsdesk - Feb 26, 2025, 1:51PM
Piper Sandler Reiterates Overweight on Jazz P...
Benzinga Newsdesk - Feb 26, 2025, 12:57PM
RBC Capital Maintains Outperform on Jazz Phar...
Benzinga Newsdesk - Feb 26, 2025, 11:57AM
JP Morgan Maintains Overweight on Jazz Pharma...
Benzinga Newsdesk - Feb 26, 2025, 11:05AM
Needham Maintains Buy on Jazz Pharmaceuticals...
Benzinga Newsdesk - Feb 26, 2025, 6:12AM

Tuesday, February 25, 2025

Jazz Pharmaceuticals Sees 2024 Total Revenues...
Benzinga Newsdesk - Feb 25, 2025, 4:10PM
Jazz Pharmaceuticals Q4 2024 Adj. EPS $6.60 B...
Benzinga Newsdesk - Feb 25, 2025, 4:09PM
Earnings Scheduled For February 25, 2025
Benzinga Insights - Feb 25, 2025, 3:32AM

Thursday, February 13, 2025

Jazz Pharmaceuticals shares are trading highe...
Benzinga Newsdesk - Feb 13, 2025, 8:08AM
This AstraZeneca Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Avi Kapoor - Feb 13, 2025, 7:35AM
Deep Dive Into Jazz Pharmaceuticals Stock: Analyst Perspectives (9 Ratings)
Benzinga Insights - Feb 13, 2025, 7:00AM
Wells Fargo Upgrades Jazz Pharmaceuticals to ...
Benzinga Newsdesk - Feb 13, 2025, 6:23AM

Monday, December 16, 2024

Jazz Pharmaceuticals Announces CEO Succession...
Benzinga Newsdesk - Dec 16, 2024, 4:07PM

Thursday, December 12, 2024

Piper Sandler Reiterates Overweight on Jazz P...
Benzinga Newsdesk - Dec 12, 2024, 12:56PM
RBC Capital Reiterates Outperform on Jazz Pha...
Benzinga Newsdesk - Dec 12, 2024, 11:05AM
Needham Reiterates Buy on Jazz Pharmaceutical...
Benzinga Newsdesk - Dec 12, 2024, 6:31AM

Tuesday, December 10, 2024

RBC Capital Reiterates Outperform on Jazz Pha...
Benzinga Newsdesk - Dec 10, 2024, 9:46AM

Monday, December 09, 2024

CBD Drug For Tuberous Sclerosis: Caregivers Continue Epidiolex Treatment Citing Seizure Reduction And Cognitive Improvements
Jelena Martinovic - Dec 9, 2024, 1:53PM

Friday, December 06, 2024

Jazz Pharmaceuticals To Showcase New Real-Wor...
Benzinga Newsdesk - Dec 6, 2024, 4:06PM

Thursday, December 05, 2024

Jazz Pharmaceuticals Announced That Zanidatam...
Benzinga Newsdesk - Dec 5, 2024, 7:49AM

Tuesday, December 03, 2024

Jazz Pharmaceuticals To Present Advancements ...
Benzinga Newsdesk - Dec 3, 2024, 8:01AM

Wednesday, November 27, 2024

Axsome Therapeutics' AXS-12 Data For Sleeping Disorder Boosts Confidence In Approval And Market Potential, Analyst Says
Vandana Singh - Nov 27, 2024, 1:23PM

Friday, November 22, 2024

HC Wainwright & Co. Reiterates Buy on Jazz Ph...
Benzinga Newsdesk - Nov 22, 2024, 4:36AM

Thursday, November 21, 2024

Needham Reiterates Buy on Jazz Pharmaceutical...
Benzinga Newsdesk - Nov 21, 2024, 12:56PM
FDA Greenlights Jazz Pharma's Cancer Drug, A Milestone For Zymework
Vandana Singh - Nov 21, 2024, 8:57AM
Piper Sandler Reiterates Overweight on Jazz P...
Benzinga Newsdesk - Nov 21, 2024, 8:56AM
Jazz Pharmaceuticals and Zymeworks shares are...
Benzinga Newsdesk - Nov 21, 2024, 8:32AM
Reported Earlier, Jazz Pharmaceuticals Secure...
Benzinga Newsdesk - Nov 21, 2024, 1:31AM

Monday, November 18, 2024

Baird Maintains Outperform on Jazz Pharmaceut...
Benzinga Newsdesk - Nov 18, 2024, 7:34AM

Thursday, November 14, 2024

Neena M Patil Executes Sell Order: Offloads $456K In Jazz Pharmaceuticals Stock
Benzinga Insights - Nov 14, 2024, 10:03AM

Friday, November 08, 2024

UK Parents Want National Health Service To Allow Cannabis For Children With Epilepsy
Nina Zdinjak - Nov 8, 2024, 10:12AM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved